FDA backs new $82M mRNA manufacturing center at MIT
The Massachusetts Institute of Technology will be aiming to design and install a new continuous mRNA manufacturing platform, with help from the federal government.
According to MIT on Thursday, the project, backed by $82 million from the FDA’s Center for Biologics Evaluation and Research over three years, will aim to advance the field of mRNA therapeutics by providing a continuous manufacturing template for other companies to follow, while facilitating collaboration throughout the biopharma industry.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.